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*Author for correspondence at Wellcome/CRC InstituteIt has been difficult to follow many of the dramatic changes
in cell fate and cell migration during mouse development.
This is because there has been no enduring marker that
would allow cells to be recognised in the living embryo. We
believe that we have overcome this problem by developing
a novel form of green fluorescent protein, named MmGFP,
that proves to be easily visible and non toxic to mouse cells
and does not perturb embryogenesis. We show that
synthetic mRNA encoding MmGFP can be injected into
blastomeres to follow the fate of their progeny during
preimplantation development. We have made a stable
embryonic stem cell line that expresses MmGFP and intro-
duced these fluorescent cells into mouse embryos. For the
first time, we have been able to follow the fate of embryonic
stem cells in living embryos and to observe directly the con-
tribution of these cells to distinct lineages of the postim-
plantation embryo. This approach should lead to a more
complete description of the dynamics of cell fate in the
mouse.
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SUMMARYINTRODUCTION
In order to trace cell lineages during development, a cell
marker is needed. Ideally this would cause no interference with
normal development and be visualised in the living tissue.
Exogenously applied vital dyes such as DiI are very useful, but
a controllable endogenously expressed marker would be
preferable in many instances. Moreover, such a marker might
be usable as a reporter gene to visualise cell-specific control of
gene expression. Recently, proteins derived from cnidaria,
which have a property of being spontaneously fluorescent, have
been described and one, in particular, the green fluorescent
protein (GFP) from Aequorea victoria has been cloned
(Prasher, 1995) and is able to function as a vital cell marker in
many organisms, including nematodes, insects, fish and frogs
(Amsterdam et al., 1995; Chalfie et al., 1994; Kerrebrock et al.,
1995; Peters et al., 1995; Prasher, 1995; Wang and Hazelrigg,
1994; Zernicka-Goetz et al., 1996). In the mouse, a favourable
method for tracing cells would be to introduce a vital marker
into embryonic stem (ES) cells (Evans and Kaufman, 1981).
However, no ES cell lines expressing GFP have been reported
until now. We have found that neither the wild-type protein,
nor many of the mutants described so far (Ehrig et al., 1995;
Heim et al., 1994, 1995), are visible in stable mouse ES cell
lines. Therefore, we have developed a novel form of the
protein, named MmGFP, that can be used in the mouse, either
when expressed as a transgene, or when microinjected as
mRNA. MmGFP allowed us to follow the fate of early blas-tomeres throughout preimplantation development and to
visualise the progeny of ES cells during both preimplantation
and postimplantation development. Our results demonstrate the
potential of MmGFP to be used as a cell fate marker for the
mouse. 
MATERIALS AND METHODS
Mutations were introduced into mGFP5 (Siemering et al., 1996) by
PCR mutagenesis as previously described (Zernicka-Goetz et al.,
1996). Constructs were sequenced using an ABI automatic sequencer.
Embryos were collected from F1 (CBA/H· C57BL/10) mice induced
to superovulation by injections of 5 IU of pregnant mare’s serum
gonadotrophin (PMSG, Intervet) and 5 IU of human chorionic
gonadotrophin (hCG, Intervet) 48-52 hours apart and mated to F1
males. Synthetic MmGFP RNA was transcribed with T3 polymerase
from the GFP.RN3 vector (Zernicka-Goetz et al., 1996), and ~12 pl
at 80 m g/ml injected into one blastomere of a late 2-cell-stage embryo
(40-44 hours after hCG). Both injection and holding pipettes were
straight and held in micromanipulators (Nikon). The holding pipette
was drawn from hard glass capillary tubes and flame polished to a flat,
blunt end (id: ~10 m m). The injection pipette was made from capil-
laries with an internal filament (Clark Biomedical Supplies, UK)
pulled on an automatic micropipette puller (Sutter, USA). RNA was
loaded into the back of the capillary and the tip broken against the
holding pipette just before injection. Microinjections were performed
using air pressure from a gas-tight syringe. All injections were made
into embryos suspended in drops of M2 medium supplemented with
4 mg/ml BSA (M2+BSA) (Whittingham, 1971) surrounded by






F Gparaffin oil in a depression slide. After injection embryos were
cultured in Whitten’s medium (Whitten, 1971) under paraffin oil at
37˚C until the blastocyst stage. For visualisation under the confocal
microscope embryos were transfered to flattened capillary tubes filled
with M2+BSA medium and sealed at the ends. 
CCB embryonal stem cells were electroporated with a 1:10 ratio of
pCdc2-MmGFP and a DNA construct carrying a neomycin-resistant
(neoR) gene under the PGK promoter (Colledge et al., 1994). Cells
were selected in 200 m g/ml G418 for 14 days. 43 clones resistant to
G418 were identified of which 21 visibly expressed MmGFP under
epifluorescence microscopy with a FITC filter set (BP 450-490 nm,
DM 512 nm, BF 515 nm). To induce ES cells to differentiate, cells
were aggregated in culture in order to form embryonal bodies (Martin
and Evans, 1975). These were allowed to attach to dishes after 10
days. Chimaeras were formed by aggregation of 8- to 16-cell-stage
embryos and CCB cells transformed with pCdc2-MmGFP. Embryos
were pretreated (3 minutes) with a 1:20 dilution of phytohemaglutinin
(Gibco) before aggregation with CCB cells in M2+BSA under
paraffin oil at 37˚C and cultured in vitro for 24 hours before transfer
to foster mothers. The expression of MmGFP was examined during
embryogenesis between 6.5 and 9.5 days p.c. Cells and embryos were
imaged on a Nikon Optiphot-2 using the 488 nm line of a KrAr laser
for MmGFP, and the 568 nm laser line for autofluorescence, on a Bio-
Rad 1024 confocal microscope with a triple dichroic filter block.
RESULTS
We based MmGFP on mGFP5 (Siemering et al., 1996), which
has two mutations, V163A and S175G, that improve the
folding of the apoprotein and, therefore, its solubility, at higher
temperatures. There are also codon usage changes that remove
a cryptic splice site recognised in plants (Haseloff and Amos,
1995). Two further mutations, F64L and S65T, were introduced
by PCR mutagenesis. The S65T mutation enhances the blue
light absorption of GFP (Heim et al., 1995) and the F64L
mutation (Cormack et al., 1996) enhances its solubility in
bacterial cells, and therefore may also improve apoprotein
folding in mammalian cells. (MmGFP also contains two appar-
ently silent mutations, H25Y and G191D, that do not measur-
ably affect fluorescence intensity.) MmGFP matures well at
37˚C and is easily detectable in living mammalian cells using
a standard FITC filter set. 
To be able to follow the lineage of proliferating cells during
development, we placed the Mm GFP cDNA under the control
of the human cdc2 promoter, which is repressed in quiescent
cells (Dalton, 1992). We used an 850 bp region of the cdc2
promoter and inserted MmGFP 60 bp downstream of the major
transcriptional start site and upstream of the SV40 small t
intron and poly adenylation signal. This construct was intro-
duced into ES cells by electroporation with a plasmid encoding
the neo resistance gene under the PGK promoter. MmGFP was
detected in neomycin-resistant cells by epifluorescence
microscopy, and was present in the nucleus and the cytoplasmFig. 1. MmGFP is visible in ES cells in culture but not in non-
proliferating, differentiated cells. Confocal images (A,C,E,G) and
transmitted light images (B,D,F). (A,B) Control ES cell. (C,D) ES
cell expressing MmGFP under the cdc2 promoter. The diameter of an
ES cell is approximately 10 m m. (E) Colony of MmGFP-expressing
ES cells. (F,G) Areas of non-proliferating, differentiated cells (d)
derived from embryonal bodies and proliferating ES cells (es)
expressing MmGFP are shown. 
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Fig. 2. Blastomeres injected with MmGFP mRNA can be followed
through preimplantation development. Fluorescence (A,C,E,G,I) and
transmitted light (B,D,F,H,J) images of a developing mouse embryo.
(A,B) 2-cell stage; (C,D) 4-cell stage; (E,F) 8-cell stage; (G,H)
morula; (I,J) blastocyst. G-I show single optical sections of the
imaged embryo. The diameter of the embryo is ~85 m m. 
Fig. 3. Colonisation of preimplantation embryos by MmGFP-
expressing ES cells. Fluorescence (A,C) and transmitted light images
(B,D) of morula stage chimaeric embryo (A,B) and chimaeric
blastocyst (C,D). The diameter of the embryo is ~85 m m. (Fig. 1A,C,E). We confirmed that the fluorescence was due to
MmGFP by immunoblotting cell lysates with a specific anti-
GFP antibody. These stable ES cell lines have continued to
express MmGFP under the cdc2 promoter after several months
in culture. To demonstrate that MmGFP expressed from the
cdc2 promoter can act as a marker for proliferating cells, we
induced MmGFP-expressing ES cells to exit the cell cycle and
differentiate in culture. Indeed, we were able to detect differ-
entiated, non-dividing cells that did not show MmGFP fluo-
rescence (Fig. 1F,G). 
We then asked whether MmGFP could provide an enduring
marker when its synthetic mRNA was injected into early blas-
tomeres of the mouse embryo. We injected MmGFP mRNA
into one blastomere at the late 2-cell-stage embryo and showed
that the progeny of this cell can be followed until the blasto-
cyst stage (Fig. 2). These experiments also showed that
frequent viewing by confocal microscopy did not perturb
embryonic development.
We wished to determine whether ES cells expressing
MmGFP could be identified during embryogenesis and
whether they could contribute to normal mouse development.
We produced chimaeras by aggregating ES cells with 8- to 16-
cell-stage embryos and followed marked cells during preim-
plantation development in vitro (Fig. 3). We found MmGFP-
expressing cells in the morula (Fig. 3A,B), and in blastocysts
our ES cells appear to contribute both to inner cell mass (ICM)
and trophectoderm (Fig. 3C,D). These chimaeric blastocysts,
and blastocysts into which marked ES cells were directly
injected, were transplanted to the uteri of foster mothers to
allow their implantation and further development. We
examined the expression of MmGFP during embryogenesis
between 6.5 and 9.5 days of development. Gastrulation in the
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Fig. 4. Developmental potential of
MmGFP-expressing ES cells in
postimplantation embryos.
(A) Fluorescence image of an
optical section of a 6.5 day p.c.
chimaeric embryo. MmGFP-
expressing cells are seen in a large
proportion of the embryonic
ectoderm (indicated by the arrow).
The length of an embryo at this
stage is approximatly 1 mm.
(B,C) Fluorescence (B) and
transmitted light (C) images of a 7
day p.c. chimaeric embryo
showing MmGFP expression in
individual cells of the embryonic
ectoderm. (D,E) Fluorescence (D)
and transmitted light (E) image of
an optical section of tissues from
the mid trunk region of a 9.5 day
p.c. chimaeric embryo with
MmGFP-expressing cells in the
surface ectoderm and
neuroepithelium. Somites are largely derived from host embryonic cells. (F) Fluorescence image of cells from a primary culture of fibroblasts
established from the adult skin with pigmented hair (i. e. of ES cell orgin) of chimaeric mice. Two MmGFP-expressing cells (arrowed) can be
distinguished by their bright green fluorescence from two non-GFP-expressing cells (marked with a *). (The bright dot on the bottom of the
figure is a refractive dust particle).mouse begins at about day 6.5 p.c. and is associated with rapid
cell proliferation. Analysis of the cell number and mitotic index
has shown that the cells of the primitive ectoderm divide
extremely rapidly between 5.5 and 7.5 days of development
(Snow, 1977). Thus, as could be predicted, cells in the
embryonic ectoderm showed strong MmGFP expression from
the cdc2 promoter (Fig. 4A,B). We found MmGFP in a variety
of different proliferating cell types in apparently normal tissues
at 9.5 day p.c. (Fig. 4D,E) and normal development was
confirmed when chimeric embryos developed to term and into
healthy adult mice. MmGFP expression could be detected in
primary fibroblast cultures established from the skin of adult
chimaeric mice (Fig. 4F).
DISCUSSION
In this paper, we have described MmGFP, a novel, autonomous
marker for living cells in the mouse. MmGFP contains coding
sequence mutations that increase its ability to fold up correctly
at higher temperatures, and others (S65T, I167T) that alter the
spectral properties of the chromophore. Together these
mutations generated a form of GFP that, by flow cytometry
analysis, is at least 50-fold brighter than the wild-type protein
at 37˚C (M. Jackman and J. P., unpublished observations), and
should be of substantial value in studies of mammalian devel-
opment. MmGFP allows marked cells and their progeny to be
visualised in living mouse embryos and it has enabled us to
follow the fate of ES cells in chimaeric embryos. There are still
several unanswered questions about the developmental
potential and deployment of ES cells introduced into early
embryos, many of which can only be addressed by determin-
ing the distribution of individual ES cells, and by observing
their proliferation and migration in living tissues (reviewed inGardner and Brook, 1997). Previously, although it was known
that ES cells can colonise a preimplantation embryo, it has only
been possible to distinguish them from carrier embryo cells by
using ES cells expressing lacZ and staining fixed embryos, or
by assaying for isoenzymes. We can now tackle these issues
using MmGFP.
Our modified GFP provides the means to follow the devel-
opmental potential and distribution of cells at successive stages
in the development of the same, living, embryo. We have
shown that it is possible to use MmGFP either as a stable cell
marker when the cDNA is integrated, or as an enduring marker
when the mRNA is injected into cells. Our studies have shown
that visualisation of MmGFP-expressing embryos under the
confocal microscope did not perturb development, and that the
protein was not toxic. MmGFP allowed us to follow the fate
of cells throughout the whole of preimplantation development,
which can take place in vitro. It should also be possible to trace
cell fate in 6.5- to 8.5-day-old embryos, since embryos at these
stages can be recovered from the mother and cultured in vitro
for a further 2 days, a period extending from just before gas-
trulation to early organogenesis. Although Ikawa et al. (1995)
reported mice expressing GFP after injection of a transgene
into the male pronucleus, their study used wild-type GFP,
which, in our hands, is invisible in ES cells. Also, all other
published studies using GFP in mammalian cells have needed
to use a modified form to achieve a visible signal, even when
overexpressed in transiently transfected cells (Hampton et al.,
1996; Heim et al., 1994; Marshall et al., 1995; Olson et al.,
1995; Pines, 1995; Rizzuto et al., 1995).
The results that we describe should have a major impact on
future studies of mammalian embryogenesis. The novel ability
to visualise marked cells in living embryos has implications for
both cell migration and cell lineage analyses. When expressed
under tissue-specific promoters, MmGFP should be a useful
1137Following mouse cell fatereporter for mapping the lineages of specific cell types. Such
analyses could be extended using site-specific recombination
at later developmental stages to delineate the fates of subpop-
ulations of cells. Furthermore, MmGFP driven by the cdc2
promoter promises to allow the domains of cell proliferation
to be traced throughout embryogenesis and postnatal develop-
ment. 
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